IMVT Stock Price
Immunovant, Inc.
$27.90
-$0.81(-2.82%)
35
Overall
40
Value
36
Tech
31
Quality
Market Cap
$5.76B
Volume
1.77M
52W Range
$16.77 - $45.42
Target Price
$47.72
IMVT stock price is $27.90 (-2.82% on the day), giving Immunovant, Inc. a market cap of $5.76B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IMVT Stock Overview
- Price
- $27.90
- Previous close
- $28.71
- Open
- $28.46
- Market cap
- $5.76B
- P/E ratio
- -11.4
- 52-week range
- $16.77 - $45.42
- 1-year price target
- $47.72
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 35
About Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMVT | $27.90 | -2.8% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |